MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5114/aic.2020.99257

Медицинская библиотека · Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2020

Transcatheter pulmonary valve implantation in 100 patients: a 10-year single-center experience.

Rużyłło Witold, Biernacka Elżbieta K, Woźniak Olgierd, Kowalski Mirosław, Śpiewak Mateusz, Cicha-Mikołajczyk Alicja, Szczęsny Aleksander, Kuśmierczyk Mariusz, Hoffman Piotr, Demkow Marcin

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Transcatheter pulmonary valve implantation (TPVI) is a non-surgical method of treatment for patients with right ventricular outflow tract (RVOT) dysfunction after surgical repair of congenital heart defects (CHD).

AIM: To evaluate the long-term results of TPVI performed in a single center.Material and methods: Over 10 years, TPVI was performed in 100 patients (mean age: 26.4 ±8.1 years), using Melody Medtronic or Sapien Edwards valves.

RESULTS

The initial success rate of TPVI was 93%. In 7 cases (5 urgent), a switch to surgical intervention was necessary due to periprocedural complications (all patients survived). Following TPVI, none of the 93 patients had severe pulmonary regurgitation. The pulmonary gradient decreased from 49.0 ±37.8 before to 27.6 ±14.9 mm Hg directly after TPVI (p < 0.0001). Right ventricular end-diastolic volume decreased, while NYHA class and pVO2 uptake significantly improved in 1 year after TPVI. Freedom from reintervention was 100% in 1 year. Freedom from serious adverse events was 86% in mean 5.5 years of observation. The main reason for reintervention was infective endocarditis (IE) (1.6% patients/year). Increased risk of IE was associated with severe PS before valve implantation and the suboptimal result of TPVI. The incidence of IE seems to be lower in patients treated permanently with antiplatelet therapy (1.8% vs. 0.9% patients/year, NS).

CONCLUSIONS

TPVI is a safe and effective method of treatment in patients with RVOT dysfunction after surgical correction of CHD. To achieve a good outcome, precise patient selection and rigorous IE prevention are necessary.

Для цитирования: Rużyłło Witold, Biernacka Elżbieta K, Woźniak Olgierd, Kowalski Mirosław, Śpiewak Mateusz, Cicha-Mikołajczyk Alicja, Szczęsny Aleksander, Kuśmierczyk Mariusz, Hoffman Piotr, Demkow Marcin. Transcatheter pulmonary valve implantation in 100 patients: a 10-year single-center experience.. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology. 2020. DOI: 10.5114/aic.2020.99257.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.